Loading…
Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening
Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels abo...
Saved in:
Published in: | Current oncology (Toronto) 2024-10, Vol.31 (10), p.6395-6405 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953 |
container_end_page | 6405 |
container_issue | 10 |
container_start_page | 6395 |
container_title | Current oncology (Toronto) |
container_volume | 31 |
creator | Sheetz, Tyler Posid, Tasha Khuhro, Aliza Scimeca, Alicia Beebe, Sarah Gul, Essa Dason, Shawn |
description | Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics.
A survey was completed by 906 male-identifying participants (age > 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal/family history (9), PCa/PSA knowledge (41), and opinions regarding PSAS (45).
The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier (
< 0.001). A number of misconceptions were evident in the responses.
Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa. |
doi_str_mv | 10.3390/curroncol31100475 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8a47c58e8bd1473f857a144ac344d525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A814095788</galeid><doaj_id>oai_doaj_org_article_8a47c58e8bd1473f857a144ac344d525</doaj_id><sourcerecordid>A814095788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953</originalsourceid><addsrcrecordid>eNptkt9vFCEQxzdGY2v1D_DFkPjiy1VmgWV5MpeLrU3atPHHM-Fg2NLswQm7Tfzv5bza9KLhATLz_X4yzEzTvAV6ypiiH-2cc4o2jQyAUi7Fs-YYJPQLKVv1_Mn7qHlVyh2ljEkpXzZHTHEBUqrjZn2DuWzRTuEeCzHRkatQbIXidgopFpJ8jZLrOIaIZOnmcSJXZkSySrcpT-QrDia7EAdyk1OZzFQzproz-WYzYqyZ180Lb8aCbx7uk-bH2efvqy-Ly-vzi9XycmE5iGmhWrSdU8YgSuagE1SpzlvftZ6Ba5mX1AJ1YD3jnAvBOiM866RoKa6dEuykudhzXTJ3epvDxuRfOpmg_wRSHrTJU7Aj6t5waUWP_doBl8z3Qhrg3NiKdqLdsT7tWdt5vUFnMU7ZjAfQw0wMt3pI9xpA0K4DVgkfHgg5_ZyxTHpTG4vjaCKmuWgGLRWq76Gv0vd76VAbq0P0qSLtTq6XPXCqhOx3qtP_qOpxuAl1YuhDjR8YYG-wdTIlo38sH6je7Y_-Z3-q593Tfz86_i4M-w2F1sLl</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3120598818</pqid></control><display><type>article</type><title>Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening</title><source>PubMed (Medline)</source><creator>Sheetz, Tyler ; Posid, Tasha ; Khuhro, Aliza ; Scimeca, Alicia ; Beebe, Sarah ; Gul, Essa ; Dason, Shawn</creator><creatorcontrib>Sheetz, Tyler ; Posid, Tasha ; Khuhro, Aliza ; Scimeca, Alicia ; Beebe, Sarah ; Gul, Essa ; Dason, Shawn</creatorcontrib><description>Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics.
A survey was completed by 906 male-identifying participants (age > 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal/family history (9), PCa/PSA knowledge (41), and opinions regarding PSAS (45).
The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier (
< 0.001). A number of misconceptions were evident in the responses.
Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa.</description><identifier>ISSN: 1718-7729</identifier><identifier>ISSN: 1198-0052</identifier><identifier>EISSN: 1718-7729</identifier><identifier>DOI: 10.3390/curroncol31100475</identifier><identifier>PMID: 39451779</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adult ; Adults ; Aged ; Cancer ; Cohort Studies ; CUA guidelines ; Diagnosis ; Early Detection of Cancer - methods ; Health Knowledge, Attitudes, Practice ; Humans ; Male ; Middle Aged ; Prostate cancer ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - diagnosis ; PSA ; PSA screening ; Surveys ; Surveys and Questionnaires ; USPSTF</subject><ispartof>Current oncology (Toronto), 2024-10, Vol.31 (10), p.6395-6405</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953</cites><orcidid>0000-0002-4440-1477</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506613/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506613/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39451779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sheetz, Tyler</creatorcontrib><creatorcontrib>Posid, Tasha</creatorcontrib><creatorcontrib>Khuhro, Aliza</creatorcontrib><creatorcontrib>Scimeca, Alicia</creatorcontrib><creatorcontrib>Beebe, Sarah</creatorcontrib><creatorcontrib>Gul, Essa</creatorcontrib><creatorcontrib>Dason, Shawn</creatorcontrib><title>Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening</title><title>Current oncology (Toronto)</title><addtitle>Curr Oncol</addtitle><description>Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics.
A survey was completed by 906 male-identifying participants (age > 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal/family history (9), PCa/PSA knowledge (41), and opinions regarding PSAS (45).
The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier (
< 0.001). A number of misconceptions were evident in the responses.
Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa.</description><subject>Adult</subject><subject>Adults</subject><subject>Aged</subject><subject>Cancer</subject><subject>Cohort Studies</subject><subject>CUA guidelines</subject><subject>Diagnosis</subject><subject>Early Detection of Cancer - methods</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prostate cancer</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>PSA</subject><subject>PSA screening</subject><subject>Surveys</subject><subject>Surveys and Questionnaires</subject><subject>USPSTF</subject><issn>1718-7729</issn><issn>1198-0052</issn><issn>1718-7729</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkt9vFCEQxzdGY2v1D_DFkPjiy1VmgWV5MpeLrU3atPHHM-Fg2NLswQm7Tfzv5bza9KLhATLz_X4yzEzTvAV6ypiiH-2cc4o2jQyAUi7Fs-YYJPQLKVv1_Mn7qHlVyh2ljEkpXzZHTHEBUqrjZn2DuWzRTuEeCzHRkatQbIXidgopFpJ8jZLrOIaIZOnmcSJXZkSySrcpT-QrDia7EAdyk1OZzFQzproz-WYzYqyZ180Lb8aCbx7uk-bH2efvqy-Ly-vzi9XycmE5iGmhWrSdU8YgSuagE1SpzlvftZ6Ba5mX1AJ1YD3jnAvBOiM866RoKa6dEuykudhzXTJ3epvDxuRfOpmg_wRSHrTJU7Aj6t5waUWP_doBl8z3Qhrg3NiKdqLdsT7tWdt5vUFnMU7ZjAfQw0wMt3pI9xpA0K4DVgkfHgg5_ZyxTHpTG4vjaCKmuWgGLRWq76Gv0vd76VAbq0P0qSLtTq6XPXCqhOx3qtP_qOpxuAl1YuhDjR8YYG-wdTIlo38sH6je7Y_-Z3-q593Tfz86_i4M-w2F1sLl</recordid><startdate>20241020</startdate><enddate>20241020</enddate><creator>Sheetz, Tyler</creator><creator>Posid, Tasha</creator><creator>Khuhro, Aliza</creator><creator>Scimeca, Alicia</creator><creator>Beebe, Sarah</creator><creator>Gul, Essa</creator><creator>Dason, Shawn</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4440-1477</orcidid></search><sort><creationdate>20241020</creationdate><title>Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening</title><author>Sheetz, Tyler ; Posid, Tasha ; Khuhro, Aliza ; Scimeca, Alicia ; Beebe, Sarah ; Gul, Essa ; Dason, Shawn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Aged</topic><topic>Cancer</topic><topic>Cohort Studies</topic><topic>CUA guidelines</topic><topic>Diagnosis</topic><topic>Early Detection of Cancer - methods</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prostate cancer</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>PSA</topic><topic>PSA screening</topic><topic>Surveys</topic><topic>Surveys and Questionnaires</topic><topic>USPSTF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheetz, Tyler</creatorcontrib><creatorcontrib>Posid, Tasha</creatorcontrib><creatorcontrib>Khuhro, Aliza</creatorcontrib><creatorcontrib>Scimeca, Alicia</creatorcontrib><creatorcontrib>Beebe, Sarah</creatorcontrib><creatorcontrib>Gul, Essa</creatorcontrib><creatorcontrib>Dason, Shawn</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Current oncology (Toronto)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheetz, Tyler</au><au>Posid, Tasha</au><au>Khuhro, Aliza</au><au>Scimeca, Alicia</au><au>Beebe, Sarah</au><au>Gul, Essa</au><au>Dason, Shawn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening</atitle><jtitle>Current oncology (Toronto)</jtitle><addtitle>Curr Oncol</addtitle><date>2024-10-20</date><risdate>2024</risdate><volume>31</volume><issue>10</issue><spage>6395</spage><epage>6405</epage><pages>6395-6405</pages><issn>1718-7729</issn><issn>1198-0052</issn><eissn>1718-7729</eissn><abstract>Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics.
A survey was completed by 906 male-identifying participants (age > 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal/family history (9), PCa/PSA knowledge (41), and opinions regarding PSAS (45).
The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier (
< 0.001). A number of misconceptions were evident in the responses.
Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39451779</pmid><doi>10.3390/curroncol31100475</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-4440-1477</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1718-7729 |
ispartof | Current oncology (Toronto), 2024-10, Vol.31 (10), p.6395-6405 |
issn | 1718-7729 1198-0052 1718-7729 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_8a47c58e8bd1473f857a144ac344d525 |
source | PubMed (Medline) |
subjects | Adult Adults Aged Cancer Cohort Studies CUA guidelines Diagnosis Early Detection of Cancer - methods Health Knowledge, Attitudes, Practice Humans Male Middle Aged Prostate cancer Prostate-Specific Antigen - blood Prostatic Neoplasms - diagnosis PSA PSA screening Surveys Surveys and Questionnaires USPSTF |
title | Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A36%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Perspectives%20and%20Misconceptions%20of%20an%20Online%20Adult%20Male%20Cohort%20Regarding%20Prostate%20Cancer%20Screening&rft.jtitle=Current%20oncology%20(Toronto)&rft.au=Sheetz,%20Tyler&rft.date=2024-10-20&rft.volume=31&rft.issue=10&rft.spage=6395&rft.epage=6405&rft.pages=6395-6405&rft.issn=1718-7729&rft.eissn=1718-7729&rft_id=info:doi/10.3390/curroncol31100475&rft_dat=%3Cgale_doaj_%3EA814095788%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3120598818&rft_id=info:pmid/39451779&rft_galeid=A814095788&rfr_iscdi=true |